Yuyong Zhou

560 total citations · 1 hit paper
11 papers, 348 citations indexed

About

Yuyong Zhou is a scholar working on Infectious Diseases, Computational Theory and Mathematics and Animal Science and Zoology. According to data from OpenAlex, Yuyong Zhou has authored 11 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 4 papers in Computational Theory and Mathematics and 3 papers in Animal Science and Zoology. Recurrent topics in Yuyong Zhou's work include SARS-CoV-2 and COVID-19 Research (8 papers), Computational Drug Discovery Methods (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yuyong Zhou is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Computational Drug Discovery Methods (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yuyong Zhou collaborates with scholars based in Denmark, Germany and China. Yuyong Zhou's co-authors include Ulrik Fahnøe, Anna Offersgaard, Judith M. Gottwein, Karen Anbro Gammeltoft, Jens Bukh, Santseharay Ramírez, Long V. Pham, Carlota Fernandez-Antunez, Alekxander Binderup and Günther H. Peters and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Science Advances.

In The Last Decade

Yuyong Zhou

10 papers receiving 344 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system

2022 132 citations Yuyong Zhou, Karen Anbro Gammeltoft et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuyong Zhou Denmark	7	206	118	96	73	32	11	348
Isabelle Fonta France	9	176 0.9×	91 0.8×	98 1.0×	68 0.9×	35 1.1×	20	390
Karen Anbro Gammeltoft Denmark	6	186 0.9×	97 0.8×	34 0.4×	69 0.9×	21 0.7×	9	281
Mathieu Gendrot France	12	204 1.0×	130 1.1×	243 2.5×	89 1.2×	43 1.3×	32	555
Anna Offersgaard Denmark	11	226 1.1×	97 0.8×	40 0.4×	94 1.3×	21 0.7×	18	406
M. Narwal India	9	172 0.8×	105 0.9×	140 1.5×	102 1.4×	15 0.5×	12	363
Qingxing Wang China	5	306 1.5×	142 1.2×	34 0.4×	165 2.3×	24 0.8×	8	540
Diwakar Kumar India	9	106 0.5×	108 0.9×	41 0.4×	74 1.0×	26 0.8×	25	283
Sydney A. Majowicz United States	5	121 0.6×	87 0.7×	45 0.5×	49 0.7×	12 0.4×	5	215
Soo Young Byun South Korea	8	348 1.7×	123 1.0×	67 0.7×	161 2.2×	31 1.0×	8	593
Yinkai Duan China	5	318 1.5×	202 1.7×	29 0.3×	155 2.1×	15 0.5×	7	459

Countries citing papers authored by Yuyong Zhou

Since Specialization

Citations

This map shows the geographic impact of Yuyong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuyong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuyong Zhou more than expected).

Fields of papers citing papers by Yuyong Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuyong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuyong Zhou. The network helps show where Yuyong Zhou may publish in the future.

Co-authorship network of co-authors of Yuyong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yuyong Zhou. A scholar is included among the top collaborators of Yuyong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuyong Zhou. Yuyong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Zhou, Yuyong, Karen Anbro Gammeltoft, Line A. Ryberg, et al.. (2025). SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots. Emerging Microbes & Infections. 14(1). 2552716–2552716.

2.

Offersgaard, Anna, Yuyong Zhou, Z. H. Duan, et al.. (2024). An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals. Scientific Reports. 14(1). 17039–17039. 1 indexed citations

3.

Offersgaard, Anna, Shan Feng, Pavel Marichal‐Gallardo, et al.. (2023). An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals. iScience. 26(2). 105949–105949. 5 indexed citations

4.

Gammeltoft, Karen Anbro, Yuyong Zhou, Line A. Ryberg, et al.. (2023). Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir. Viruses. 15(9). 1970–1970. 10 indexed citations

5.

Zhou, Yuyong, Karen Anbro Gammeltoft, Line A. Ryberg, et al.. (2022). Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system. Science Advances. 8(51). eadd7197–eadd7197. 132 indexed citations breakdown →

6.

Zhou, Yuyong, Karen Anbro Gammeltoft, Andrea Galli, et al.. (2021). Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro. Viruses. 13(10). 2082–2082. 24 indexed citations

7.

Gammeltoft, Karen Anbro, Yuyong Zhou, Andrea Galli, et al.. (2021). Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro. Antimicrobial Agents and Chemotherapy. 65(9). e0268020–e0268020. 37 indexed citations

8.

Zhou, Yuyong, Kerry Gilmore, Santseharay Ramírez, et al.. (2021). In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. Scientific Reports. 11(1). 14571–14571. 70 indexed citations

9.

Zhou, Yuyong, Rui Wu, Feng Yao, et al.. (2018). Genomic changes in an attenuated genotype I Japanese encephalitis virus and comparison with virulent parental strain. Virus Genes. 54(3). 424–431. 4 indexed citations

10.

Zhou, Yuyong, Rui Wu, Qin Zhao, et al.. (2018). Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells. Archives of Virology. 163(5). 1351–1355. 17 indexed citations

11.

Zhou, Yuyong, et al.. (1982). Field observations on the antimalarial piperaquine.. PubMed. 95(4). 281–6. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact